SCHEMBL29552360

SCHEMBL29552360

NC(=O)c1nnc(-c2c(F)cccc2F)cc1Nc1ccc(C(=O)O)cn1

nearest known ligand 0.65

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 9/20 0.65
▸ JAK2 O60674 6/20 0.65
▸ JAK1 P23458 4/20 0.65
▸ JAK3 P52333 4/20 0.65
▸ HCAR3 P49019 3/20 0.44
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ RARA P10276 1/20 0.39
▸ RARB P10826 1/20 0.39
▸ RARG P13631 1/20 0.39
▸ GCK P35557 1/20 0.39
▸ DHODH Q02127 1/20 0.39
▸ SYK P43405 3/20 0.38
▸ KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28359209 0.94 TYK2 (0.67) TYK2JAK2JAK1JAK3MEN1
SCHEMBL29552906 0.94 TYK2 (0.67) TYK2JAK2JAK1JAK3MEN1
SCHEMBL29552312 0.85 TYK2 (0.58) TYK2JAK2JAK1JAK3MEN1
SCHEMBL28362682 0.85 TYK2 (0.58) TYK2JAK2JAK1JAK3MEN1
SCHEMBL29552169 0.85 TYK2 (0.58) TYK2JAK2JAK1JAK3MEN1
SCHEMBL29552249 0.84 TYK2 (0.58) TYK2JAK2JAK1JAK3MEN1
SCHEMBL28359236 0.84 TYK2 (0.58) TYK2JAK2JAK1JAK3MEN1
SCHEMBL29552180 0.83 TYK2 (0.60) TYK2JAK2JAK1JAK3DHODH
SCHEMBL28358935 0.82 TYK2 (0.61) TYK2JAK2JAK1JAK3SYK
SCHEMBL28362555 0.81 JAK1 (0.52) TYK2JAK2JAK1JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110818641-B Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2022-10-14 — — CN disclosed
WO-2022032484-A1 PYRIDAZINE-3-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 北京诺诚健华医药科技有限公司 2022-02-17 — — WO disclosed
Send feedback